All posts by imreal

Rimidi Announces the Addition of Dr. Mark Cohen as Chief Medical Advisor


Rimidi Logo

I’m thrilled to be joining the Rimidi team as an advisor to further enhance the capabilities and offerings within the company’s clinical management platform to deliver better outcomes to a larger patient population.

Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives, today announced Mark Cohen, MD, PhD has joined Rimidi as the Chief Medical Advisor, playing a critical role in helping the company meet the demands of today’s health systems.

Dr. Cohen has spent over three decades in healthcare both as a practicing cardiac electrophysiologist and health system leader, having served as Chief of Quality, Informatics-IT Research for The Piedmont Heart Institute and as the Chief Medical Officer for Piedmont Atlanta Hospital. At Rimidi, Dr. Cohen will provide strategic counsel as the company continues to expand its Clinical Management Platform to address the most pressing clinical challenges facing health systems today as well as evolving value-based payment models.

“After following the company over the past decade and its origins of being created for clinicians, by clinicians, I’m thrilled to be joining the Rimidi team as an advisor to further enhance the capabilities and offerings within the company’s clinical management platform to deliver better outcomes to a larger patient population,” said Dr. Cohen.

The appointment of Dr. Cohen comes as the company continues its focus on implementing its enterprise remote patient monitoring and chronic disease management solutions at large Integrated Delivery Networks across the U.S. This announcement also comes as Rimidi recently announced new partnerships and integrations, as well as the recognition as one of AVIA Marketplace’s Top Remote Patient Monitoring Companies for the second consecutive year.

“We are honored to welcome Dr. Cohen to the Rimidi team,” said Lucienne Ide, MD, PhD, Founder and CEO of Rimidi. “His added clinical and operational expertise will strengthen our ability to further deliver on our mission of helping clinicians optimize data for better clinical workflows, decisions, patient care and outcomes.”

To learn more about Rimidi and its solutions, visit Rimidi.com.

About Rimidi

Created by doctors, Rimidi’s leading clinical management platform empowers healthcare organizations to optimize clinical workflows, enhance patient experiences and achieve quality objectives. By bringing together clinical decision support, remote patient monitoring and patient reported outcomes in a unified, composable, FHIR-based platform, Rimidi supports a broad range of clinical use cases and institutional priorities across large and small healthcare organizations. For more information, visit rimidi.com and follow us on Twitter and LinkedIn.

Share article on social media or email:



Lymphoma Research Foundation to Honor Esteemed Lymphoma Physician Kara Kelly, MD at Annual Gala on September 28


LRF’s Annual Gala takes place at the end of Blood Cancer Awareness Month (September), celebrating the latest advancements made in lymphoma research, patient care and the dedicated individuals and institutions who help make this possible.

The Lymphoma Research Foundation (LRF), the nation’s largest non-profit organization dedicated exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives, and patient services, will host its 2023 Annual Gala on Thursday, September 28, at the Ziegfeld Ballroom in New York City.

Honored at this year’s gala will be LRF Scientific Advisory Board (SAB) member Kara Kelly, MD, who will recieve LRF’s Distinguished Leadership Award. Kara Kelly, MD is the Waldemar J. Kaminski Endowed Chair of Pediatrics and Professor of Oncology at Roswell Park Comprehensive Cancer Center and Division Chief of Pediatric Hematology/Oncology at Oishei Children’s Hospital and the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo where she also is a Professor of Pediatrics. A pediatric oncologist with expertise in the care of children and adolescents with leukemia and lymphoma, Dr. Kelly chaired the Hodgkin lymphoma committee for the Children’s Oncology Group from 2011-2022.

“I am so incredibly honored to be receiving the Distinguished Leadership Award from the Lymphoma Research Foundation.’ said Kara Kelly, MD. ‘Over the years, LRF has truly facilitated bringing together the experts and scientists who are committed to making a difference in the lives of adolescents and young adults with lymphoma. It means so much that the organization has given me this recognition. I am eager to continue our collaborative work and research and keep improving outcomes for our patients.”

“We are excited and proud to honor Dr. Kelly with the Distinguished Leadership Award. Her accomplishments in the field of lymphoma research have impacted the lives of hundreds of thousands of patients and have been instrumental in guiding the Foundation’s adolescent and young adult lymphoma research initiative,” said Meghan Gutierrez, Chief Executive Officer of LRF.

Genmab to receive the 2023 LRF Corporate Leadership Award

The Lymphoma Research Foundation will also honor Genmab, an international biotech company specializing in creation and development of differentiated antibody therapeutics for treatment of cancer and other serious diseases. Genmab is receiving this year’s Corporate Leadership Award from LRF in recognition of being pioneers in antibody therapeutics for the treatment of cancer and supporting the Foundation’s research initiatives and educational programs.

The Lymphoma Research Foundation will also honor Genmab, an international biotech company specializing in creation and development of differentiated antibody therapeutics for treatment of cancer and other serious diseases. Genmab is receiving this year’s Corporate Leadership Award from LRF in recognition of being pioneers in antibody therapeutics for the treatment of cancer and supporting the Foundation’s research initiatives and educational programs.

“We are honored to be recognized by the Lymphoma Research Foundation for our commitment to improving the lives of people affected by cancer,” said Brad Bailey, Senior Vice President and General Manager, US at Genmab. “As a company at the forefront of advancing antibody-based science, we recognize the criticality of accelerating innovative research to address urgent needs within the lymphoma community. We are proud to support the important work of the Lymphoma Research Foundation in achieving our shared goals for patients.”

The Annual Gala takes place at the end of Blood Cancer Awareness Month (September), celebrating the latest advancements made in lymphoma research, patient care and the dedicated individuals and institutions who help make this possible. This year’s program includes a cocktail hour, followed by a seated dinner and awards ceremony and live auction, as well as updates on the latest LRF-funded research, programming, and patient services. LRF will also host an Emerging Philanthropists After Party following the conclusion of the program.

To learn more about the LRF Annual Gala, contact Rebecca Rausch at rrausch@lymphoma.org, or visit lymphoma.org/gala.

###

ABOUT LRF

The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $77 million in lymphoma-specific research.   

For additional information on LRF’s research, education and services, visit lymphoma.org.

Share article on social media or email:

CSG Government Solutions Selected for Program Management Office Services on the Connecticut Medicaid Enterprise Technology System Program


“CSG is a leader in providing PMO and other services for Medicaid system modernizations across the country,” says Robin Dufresne, Executive Vice President and Senior Practice Director.

CSG Government Solutions, a national leader in government program modernization, today announced that it has been selected by the Connecticut Department of Social Services (DSS) to provide Program Management and Project Support Services for the Connecticut Medicaid Enterprise Technology System (CT METS) Program, including the implementation of an Enterprise Data Warehouse and Analytics module and Enterprise Provider module.

CSG is supporting DSS’ initiative to replace their core MMIS and other systems supporting the Medicaid Enterprise with modern, modular solutions. The CSG team will provide full-service Program Management Office (PMO) services and expertise in Medicaid, enterprise architecture, system integration, Health Information Exchange, and security. The team is also providing quality assurance, risk management, schedule and resource management, and CMS certification support.

“CSG is a leader in providing PMO and other services for Medicaid system modernizations across the country,” says Robin Dufresne, Executive Vice President and Senior Practice Director. “Our team applies our Medicaid expertise and dedication to help the DSS Medicaid Enterprise make a positive impact on the health and well-being of Connecticut’s individuals, families, and communities.”

Contact:

Robin Dufresne

Senior Practice Director of Healthcare and Human Services, Child Support, and Child Welfare

CSG Government Solutions

180 N. Stetson Ave

Suite 3200

Chicago, IL 60601

312.444.2760 Fax: 312.938.2191

rdufresne@csgdelivers.com

About CSG Government Solutions:

CSG Government Solutions is a leading government operations consulting firm helping states modernize critical program enterprises. We help governments leverage innovative technology and processes to meet the challenges of administering complex programs. Founded in 1997, CSG clients include 47 state and territory governments, the U.S. Department of Health and Human Services, the U.S. Department of Labor, and large municipal governments. For more information, visit http://www.csgdelivers.com and connect with us on LinkedIn and Twitter.

Share article on social media or email:



ProPharma Announces the Appointment of Helen Hall as Global Head of Clinical Data Sciences


“I am eager to partner with ProPharma’s global team to ensure superior clinical data science solutions are delivered to our valued client partners, further enhancing our position as the global leader in the life sciences sector.”

ProPharma Group (ProPharma), the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners, today announced the appointment of Helen Hall as Global Head of Clinical Data Sciences, where she will lead clinical data management, as well as biostatistics and programming.

A seasoned leader in clinical research with over two decades of progressive experience, Hall brings an extensive knowledge base, renowned expertise, and a commendable track record of producing organizational and operational outcomes for globally recognized life sciences organizations. Prior to joining ProPharma, the world’s largest RCO (Research Consulting Organization), Hall served in several senior leadership capacities at Syneos Health (Synteract), most recently as Senior Vice President, Clinical Data Sciences and Biometrics.

Throughout her distinguished career, Hall has demonstrated exemplary leadership to achieve corporate, operational, and financial goals while strictly adhering to regulatory, Good Clinical Practice (GCP), Standard Operating Procedures (SOPs), and protocol requirements. Her countless achievementsmanaging diverse teams of data sciences and biometrics professionals, domestically and internationally, has enabled the cultivation of a collaborative, productive, and efficient atmosphere that is conducive to long-term and future-focused organizational growth.

Michael Stomberg, ProPharma’s Chief Executive Officer, said: “We are excited to welcome Helen to the team. Her proven history of driving successful results, combined with her industry expertise and acumen make her an ideal match for this pivotal role. Helen’s demonstrated leadership in data sciences, organizational transformation, team development, process creation and harmonization, and strategic client management fortify ProPharma’s commitment to improve the health and safety of patients.”

Upon her appointment, Hall shared, “I am thrilled to join ProPharma and leverage my experience in clinical research, data sciences, and biometrics to propel the company’s strategic objectives. I am eager to partner with ProPharma’s global team to ensure superior clinical data science solutions are delivered to our valued client partners, further enhancing our position as the global leader in the life sciences sector.”

ProPharma’s steadfast commitment to innovation and the ongoing advancement of its revolutionary Research Consulting Organization (RCO) model is reaffirmed with the appointment of Hall as the Global Head of Clinical Data Sciences. This strategic move ensures robust leadership and positions the organization to surpass its operational and financial targets through the delivery of unparalleled clinical data sciences worldwide.

About ProPharma

For the past 20 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. As the world’s largest RCO (Research Consulting Organization), ProPharma partners with its clients through an advise-build-operate model across the complete product lifecycle. With deep domain expertise in regulatory sciences, clinical research solutions, quality and compliance, pharmacovigilance, medical information, and R&D technology, ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate our partners’ most high-profile drug and device programs.

For more information about ProPharma, please visit: https://www.propharmagroup.com.

Share article on social media or email:

Las Vegas Endodontics Announces Fresh, Redesigned Website


Las Vegas Endodontics

Las Vegas Endodontics

We are excited to be able to offer our patients an enhanced online experience. Our new website makes it easier for patients to find the information they need in order to make an informed decision about their oral health.

Las Vegas Endodontics, a premier practice in Nevada for root canal treatment, is announcing the launch of its newly designed website: https://www.lvendo.com.

The website has been completely revamped with a fresh look and user-friendly design to make it easy for patients to find the information they need. The site features easy-to-navigate pages that allow visitors to read about the practice’s services, conditions treated, and the types of treatments provided. Visitors can also take advantage of useful resources that include information on the various technologies the practice is equipped with as well as reviews from previous patients. The website also includes new patient forms, insurance policy information, and procedure after-care instructions.

Las Vegas Endodontics is a full-service endodontic practice that is dedicated to providing its patients with the highest quality of care. The practice’s staff provides a comfortable environment and reduced wait times due to the practice’s team of endodontic specialists.

Las Vegas Endodontics is led by Dr. Benjamin Barborka, DMD whose work has been published in the Journal of Endodontics. He is joined by Dr. William Brizzee, DDS and Dr. Benjamin Brown, DMD, MSD both fellows member of the American Dental Association and the American Association of Endodontics.

“We are excited to be able to offer our patients an enhanced online experience,” said Dr. Barborka. “Our new website makes it easier for patients to find the information they need in order to make an informed decision about their oral health.”

The highly skilled endodontists of Las Vegas Endodontics are accompanied by a team of endodontic assistants who strive to deliver the best dental experience possible. The doctors pride themselves on being able to save teeth that might have otherwise been lost due to damage or decay. The practice is equipped with the latest in endodontic technology, including GentleWave root canal treatment and Cone Beam CT for three-dimensional diagnostics. The team of dental health professionals at Las Vegas Endodontics offers a wide range of services, including:


  • Root canal therapy: Root canals are a treatment for infected tooth pulp. Las Vegas Endodontics utilizes GentleWave root canal treatment to provide a more thorough and effective cleaning of the tooth pulp.
  • Endodontic retreatment: Endodontic retreatment refers to the treatment of a failed previous root canal.
  • Apicoectomy: An apicoectomy, a type of endodontic surgery, involves removing the damaged tissue near the root of the tooth.
  • Cracked teeth: Cracked teeth come in varying severities, but some may require a root canal and/or crown to prevent infection and tooth loss.
  • Traumatic injuries: The practice treats a number of dental emergencies including dislodged teeth, avulsed or knocked out teeth, and pediatric dental injuries that may require apexogenesis, which promotes the growth of the tooth root, or apexification, which is the removal of the tooth root.

About Las Vegas Endodontics

Las Vegas Endodontics is a premier endodontics practice serving patients in Las Vegas and the surrounding areas. The practice is located at 6655 W Sahara Ave Suite A-106, Las Vegas, NV 89146. To make an appointment, contact the clinic by calling 702-876-5800 or visiting the website at https://www.lvendo.com.

Share article on social media or email:

Embark Behavioral Health Expands Virtual Intensive Outpatient Program to Serve Young Adults, Adds National OCD Track


Embark Behavioral Health Logo

“We’re looking forward to the impact of Embark’s growing presence in the online mental health realm with our expansions in ages, programming, and geographies served,” said Tiffany King, vice president of Embark Behavioral Health virtual services.

Embark Behavioral Health has expanded its insurance-reimbursed virtual intensive outpatient program, Embark Virtual IOP, to serve young adults, with it now available to young people ages 12-28. In addition, the company has added an obsessive-compulsive disorder (OCD) track to the online mental health service and made the IOP available in Missouri.

“We’re looking forward to the impact of Embark’s growing presence in the online mental health realm with our expansions in ages, programming, and geographies served,” said Tiffany King, vice president of Embark Behavioral Health virtual services. “This allows us to reach a wider population in need and emphasize the power of mental health treatment in our youths and young adults today.”

Through Embark Virtual IOP services now available in Washington, D.C., and nine states (California, Arizona, Colorado, Texas, Missouri, Georgia, Virginia, Maryland, and Pennsylvania), Embark replicates the essence of face-to-face interaction by providing a comprehensive and immersive virtual environment. This allows clients to conveniently receive treatment without having to leave home, which especially benefits college students and other young adults who need flexibility and convenient access due to their busy schedules and transportation issues.

Using telehealth technologies, the Embark virtual care platform allows for real-time, secure video sessions with highly skilled and compassionate therapists. This approach fosters a strong therapeutic alliance between clinicians and clients, resulting in effective communication and personalized treatment plans.

More About the Embark OCD Track

To enhance its virtual services for youths and young adults, Embark Virtual IOP is offering an OCD track in all states where the online mental health program is available. Young people who participate in the IOP’s mood and anxiety group attend a one-hour breakout group that’s focused on exposure and response prevention (ERP) therapy as well as individual and family sessions. The group, individual, and family (or couples) sessions are led by an ERP-trained therapist.

The virtual IOP OCD track emphasizes ERP, an evidence-based approach, as it’s widely considered the treatment of choice for individuals with obsessive-compulsive disorder. As part of the track, every week, caregivers and clients will complete the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and Children’s Yale-Brown Obsessive-Compulsive Scale (CY-BOCS) for adolescents’ surveys to assess progress toward goals.

Embark Virtual IOP Overview

Embark Virtual IOP is an insurance-reimbursed program available to residents in various states across the country. Virtual IOP is ideal for adolescents, teens, and young adults as part of an after- and continuing-care plan ─ for example when they’re stepping down from a higher level of care, such as residential treatment or outdoor therapy, or up from a lower level of care, such as weekly individual therapy.

Embark Virtual IOP offers individual, family (or loved ones), and group therapy as well as psychiatry and medication management services, along with delivering evidenced-based therapy via experiential activities including yoga, sculpting, music therapy, mindfulness, and painting.

Typically, adolescents, teens, and young adults in the 12-week virtual IOP spend three hours per day for four days per week in a variety of interactive group therapy sessions and will participate in individual sessions weekly and family therapy sessions at least once every other week.

ABOUT EMBARK BEHAVIORAL HEALTH

Embark Behavioral Health is a leading network of outpatient centers and residential programs offering premier mental health treatment for preteens, teens, and young adults. Dedicated to its big mission of reversing the trends of teen and young adult anxiety, depression, and suicide by 2028, Embark offers a robust continuum of care with different levels of service and programming; has a deep legacy of over 25 years serving youth; works with families to adjust treatment in real time to improve results; treats the entire family using an evidence-based approach; and offers the highest levels of quality care and safety standards. For more information about Embark or its treatment programs, including virtual services, intensive outpatient programs (IOPs), therapeutic day treatment programs, also known as partial hospitalization programs (PHPs), residential treatment, and outdoor therapy, visit http://www.embarkbh.com.

Share article on social media or email:

UT Health Science Center San Antonio study will assess Mexican Americans and dementia risk


Typically, it is by studying populations that haven’t yet been studied that we find answers. — Sudha Seshadri, MD, UT Health San Antonio

The University of Texas Health Science Center at San Antonio has received a five-year, $15.5 million grant to conduct the San Antonio Heart and Mind Study, an investigation of why the region’s older Mexican Americans experience a higher rate of dementia than older non-Hispanic white adults. The National Institutes of Health/National Institute on Aging awarded the funding.

Claudia L. Satizabal, PhD, associate professor of population health sciences in the health science center’s Joe R. and Teresa Lozano Long School of Medicine, is the study principal investigator. She will conduct the study with colleagues of UT Health San Antonio’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases.

The new research is an extension of the San Antonio Heart Study conducted at UT Health San Antonio between 1979 and 2006. Helen P. Hazuda, PhD, professor of medicine, was a study leader during its run and provided access to the cohort and data collected in the initial study to carry out the new iteration.

“The original study enrolled participants ages 25 to 64,” Satizabal said. “The participants returned for follow-up visits, which means we have information about them from their midlife. This is precious, unique data that is hardly ever available, and it now enables us to employ a life-course approach to dementia because we have this information.”

Goal is to reconnect with surviving study participants

People on the younger end of the cohort are now in their 60s. Of the 5,158 participants who were included in the San Antonio Heart Study, about 3,000 are still alive according to a search of death records.

“We will seek to enroll as many of the surviving participants as we can in the San Antonio Heart and Mind Study,” Satizabal said. Only people who were in the original study are eligible. About 65% of the survivors are Mexican American.

Information about deceased participants will be gleaned from electronic medical records and the National Death Index. “We will look for cause of death, any potential diagnosis that was registered and whether they were part of Medicare. We will use as much information as we can to answer questions about who ultimately develops dementia,” Satizabal said.

Older Hispanics at increased risk

Alzheimer’s disease (AD) and AD-related dementias (AD/ADRD) disproportionately affect minoritized populations, according to the study summary. Compared to non-Hispanic whites, older Hispanic adults in the United States are estimated to have a 50% increased risk of AD and are projected to bear the largest relative increase in AD/ADRD cases by 2060.

Mexican Americans not only represent the largest segment of Hispanics in the United States, but they also experience a high burden of cardiometabolic diseases, which has the potential to increase AD/ADRD disparities over the next decades, the summary states.

New assessments

The San Antonio Heart Study focused on diabetes and heart disease and didn’t include brain imaging. The new study will utilize MRI and positron emission tomography (PET) to learn how much amyloid and tau, the two main proteins related to Alzheimer’s disease, is in the brains of San Antonio Heart and Mind Study participants.

“And we will do other assessments that were not done in the other studies, such as a comprehensive neuropsychological battery and studies of blood markers and cerebrospinal fluid markers indicating disease,” Satizabal said.

Filling the gap: Understanding how AD affects Mexican Americans

Sudha Seshadri, MD, professor of neurology at UT Health San Antonio and founding director of the Biggs Institute, is a senior investigator with the famed Framingham Heart Study that is an observational study of multiple generations of family members in the town of Framingham outside Boston. The study began in 1948.

Because the Framingham research is primarily in people of European ancestry, it is not the best sample in which to explore racial ethnic influences on disease such as dementia. Studies in other populations, including Mexican Americans, are needed.

“We believe the San Antonio Heart and Mind Study will fill that gap,” Seshadri said. “Studies like this are vital to understand what is unique about Hispanic populations and their risk, both in terms of genetic and environmental factors.

“And finding answers that help Hispanics is not just helpful to Hispanics,” she said. “It’s helpful to everyone in the community. Typically, it is by studying populations that haven’t yet been studied that we find answers.”

Sifting a mosaic of information

The San Antonio Heart Study captured diversity in several ways. Participants lived in different geographical areas of San Antonio, for example.

“We wanted to capture the full diversity of our population, and we didn’t want to only compare Mexican Americans to non-Hispanic whites,” Hazuda said. “Within our Mexican American study population, we wanted to compare those who lived in different neighborhoods and had varying levels of socioeconomic status.”

Satizabal added: “The Mexican American culture is unique. For example, in the barrio we know that they have big families, and maybe that supportive social network helps brain aging. Those questions are not well explored. That’s why this study is exciting.”

Other studies being done in cities such as San Diego and Miami are focused on different Hispanic subgroups originating from South America, Cuba and Puerto Rico. But in South Texas, the population is Mexican Americans.

‘An incredible resource’

“The main differential between our study and others like it is that we have midlife information, and that is something not all the other study cohorts have,” Satizabal said.

“The fact that the original study collected information on blood pressure, heart disease and diabetes starting in the late 1970s makes it an incredible research resource,” Seshadri said. “We can reconnect with the participants today and see how the last 20 to 50 years of their lives have impacted their brain structure and function.”

Participants in the original San Antonio Heart Study are encouraged to contact sahms@uthscsa.edu.

The San Antonio Heart and Mind Study is funded by the National Institute on Aging (grant number 1R01AG082360-01).

The University of Texas Health Science Center at San Antonio (UT Health San Antonio), a primary driver for San Antonio’s $44.1 billion health care and biosciences sector, is the largest academic research institution in South Texas with an annual research portfolio of more than $360 million. Driving substantial economic impact with its six professional schools, a diverse workforce of 7,900, an annual operating budget of $1.23 billion and clinical practices that provide 2.6 million patient visits each year, UT Health San Antonio plans to add more than 1,500 higher-wage jobs over the next five years to serve San Antonio, Bexar County and South Texas. To learn about the many ways “We make lives better®,” visit UTHealthSA.org.

The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases is dedicated to providing comprehensive dementia care while advancing treatment through clinical trials and research. The Biggs Institute is a National Institute on Aging (NIA)-designated Alzheimer’s Disease Research Center (ADRC). In addition to patient care and research, the Biggs Institute partners with the School of Nursing at UT Health San Antonio to offer the Caring for the Caregiver program.

Stay connected with The University of Texas Health Science Center at San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube.



Mercy Medical Center Recognized in U.S. News & World Report’s “Best Hospitals 2023-2024” Edition


Mercy Medical Center in Baltimore, Maryland

“Our doctors, nurses, and support staff…deserve enormous credit for their efforts in earning this ranking, as Mercy delivers excellent care in a compassionate setting.” — David N. Maine, M.D., President and CEO, Mercy Health Services, Mercy Medical Center

Mercy Medical Center has been recognized by U.S. News & World Report’s “Best Hospitals” rankings for 2023-2024. Among Adult Specialties, National Rankings, Mercy was rated as High Performing in Orthopedics. In Common Adult Procedures and Condition Ratings, Mercy earned High Performing status in Hip Replacement and Knee Replacement, as well as Colon Cancer Surgery.

U.S. News’ Best Hospitals evaluated more than 4,500 hospitals across 15 specialties and 21 procedures and conditions. Fewer than a third of all hospitals received any high-performing rating. An overall rating of high performing indicates a hospital was significantly better than the national average in a given procedure or condition.

“We are pleased to once again to be included in in U.S. News’ annual ‘Best Hospitals’ edition. Our doctors, nurses, and support staff in Orthopedics and Joint Replacement, The Institute for Digestive Health and Liver Disease, and all those clinical divisions deserve enormous credit for their efforts in earning this ranking, as Mercy delivers excellent care in a compassionate setting,” said Dr. David Maine, President and CEO of Mercy Health Services, Mercy Medical Center.

Dr. Maine noted that this recognition by U.S. News follows a number of recent accolades for the 149-year-old Catholic hospital, including being named one of America’s 50 Best Hospitals for Surgical Care according to research released by Healthgrades, the leading resource that connects consumers, physicians and health systems. Mercy was also named one of America’s Greatest Workplaces for Women in 2023 by Newsweek.

The Best Hospitals Specialty rankings and Procedures & Conditions methodologies factor objective measures such as risk-adjusted mortality rates, patient experience, level of nursing care and how successfully each hospital helps patients get back home.

“For 34 years, U.S. News has provided data-informed rankings to help patients and their doctors find the best hospital to treat their illness or condition,” said Ben Harder, chief of health analysis and managing editor at U.S. News. “Fewer than half of evaluated hospitals earned any High Performing rating. Hospitals that are High Performing have excelled in providing high quality care in specific procedures and/or conditions.”

A university-affiliated teaching hospital, Mercy Medical Center is nationally recognized with Magnet status for nursing excellence and named by Healthgrades as one of America’s 100 Best Hospitals for Orthopedic Surgery.

Founded in 1874 by The Sisters of Mercy, Mercy is home to the acclaimed Weinberg Center for Women’s Health & Medicine and the $400+ million, 20-story Mary Catherine Bunting Center. For more information about Mercy, visit http://www.mdmercy.com, MDMercyMedia on FACEBOOK and TWITTER, or call 1-800-M.D.-Mercy.

Share article on social media or email:

Super Doctors® Recognizes 18 U.S. Dermatology Partners Physicians as Rising Stars in Peer-Nominated Award


Super Doctors – Texas Rising Star Dermatologists

“Honors awarded based on rigorous selection processes serve as valuable tools for patients seeking quality healthcare options. We are delighted to have our talented physicians featured in such an influential list,” said Paul Singh, CEO of U.S. Dermatology Partners.

Eighteen U.S. Dermatology Partners doctors are being recognized by their peers as Super Doctors® Rising Stars in the July 2023 issue of Texas Monthly.

The rigorous selection process for Super Doctors® Rising Stars is designed to identify physicians who have attained a high degree of peer recognition and professional achievement. Each year, Super Doctors® asks physicians across the state to nominate colleagues whom they would trust with their medical care. The Super Doctors® research team then conducts an independent investigation, evaluating candidates on their peer recognition, professional achievement, and disciplinary history. The highest-ranking nominated physicians are asked to serve on a selection panel, which helps to determine the final list of Super Doctors® and Rising Stars. Doctors recognized as Rising Stars meet the same criteria as Super Doctors®, but are at the start of their careers, having been in practice for 10 years or less. In Texas, only 2.5% of all active physicians are selected for the Rising Star list.

“We are immensely proud to have eighteen of our physicians honored by their peers for their professional excellence through the Rising Star Award. Their inclusion in this esteemed list is a testament to their outstanding clinical expertise, their unwavering commitment to delivering exceptional care, and their collaborative spirit in working with their teams to best serve their patients,” said Paul Singh, Chief Executive Officer of U.S. Dermatology Partners. “Honors that are awarded based on rigorous selection processes such as the one used by the Rising Stars list serve as valuable tools for patients seeking quality healthcare options. We are delighted to have our talented physicians featured in such an influential list.”

The complete list is published in the July 2023 issue of Texas Monthly.

U.S. Dermatology Partners Super Doctors® Rising Stars 2023 Recognized for Dermatology

Sam Awan, MD – McKinney

Leon Chen, MD – Houston, Pasadena, & Sugar Land

Daniel Condie, MD – Plano, Grapevine, & Sherman

Kathryn Celeste Durham, MD – Fort Worth

Miranda Uzoma Ewelukwa, MD – Sugar Land

Matthew Hoffman, MD – Longview

Rasheen Imtiaz, MD – Baytown

Weilan Johnson, MD – Cedar Park & Georgetown

Leslie Scroggins Markle, MD – Tyler

Young McMahan, MD – Waco

Michaela Overturf, MD – Nacogdoches

Amreen Sitabkhan – Carrollton & Dallas

Lauren Snitzer, MD – Sugar Land

Valerie Truong, MD – Plano, Dallas, & Corsicana

Daniel Walker, MD – Grapevine & Keller

Gregory Walker, MD – Waco

Dustin Wilkes, DO – Granbury & Weatherford

John Jay Wofford, MD – Dallas & Plano

About U.S. Dermatology Partners

U.S. Dermatology Partners is one of the premier dermatology practices in the country, caring for nearly two million patients each year. With over 100 locations across eight states that span large metroplexes and rural, underserved communities, they provide the benefits of private, personalized levels of care paired with a network of coordinated, specialized dermatology physicians. U.S. Dermatology Partners is fervently focused on providing the highest level of compassionate and comprehensive patient-first care, making it seamless for all people to connect with dermatologists and national leaders in areas such as clinical research, psoriasis, and Mohs surgery, and gain access to state-of-the-art dermatological treatments, surgical and cosmetic dermatology. To learn more, visit usdermatologypartners.com.

Share article on social media or email:

Motif Medical Celebrates National Breastfeeding Month with Exciting Initiatives and Collaborations


Motif Celebrates National Breastfeeding Awareness Month Throughout August

August is a special month for Motif Medical, a leading provider of breastfeeding products and accessories, as it marks National Breastfeeding Month – a time dedicated to raising awareness about the importance of breastfeeding and supporting breastfeeding mothers. In celebration of this significant occasion, Motif Medical is thrilled to announce a series of initiatives and collaborations aimed at empowering and assisting mothers on their breastfeeding journey.

Complimentary Bra with Pump Purchase:

As part of their commitment to providing exceptional support to nursing mothers, Motif Medical is offering a complimentary bra with every pump purchase throughout the entire month of August. This specially designed bra is not only comfortable, but also aids in ensuring seamless pumping sessions for new mothers.

World Breastfeeding Week Promotion:

During World Breastfeeding Week (August 1 – August 7), take $10 off purchases of $50 or more on motifmedical.com. This limited-time promotion aims to make breastfeeding essentials even more accessible to mothers, and encourages the use of high-quality, effective products to support their breastfeeding journey.

Giveaway with Pumpin Pals:

Motif Medical has partnered with Pumpin Pals who offer pumping accessories to improve comfort & milk supply for breastfeeding moms to host an exclusive giveaway event from August 1 – August 7. Participants will stand a chance to win over $2,200 worth of incredible prizes that enhance their breastfeeding experience.

Collaboration with Yoga Pointe:

Understanding the importance of overall well-being during the postpartum period, Motif Medical is excited to announce a virtual collaboration with Yoga Pointe in Florida.Together, they’ll offer a postpartum yoga flow via IG Reels to promote physical and mental health throughout this transformative stage of life.

Educational Content by IBCLCs:

To equip mothers with valuable information and guidance, Motif Medical is collaborating with International Board Certified Lactation Consultants (IBCLCs). Throughout National Breastfeeding Month, these expert consultants will share educational content, tips, and advice on various breastfeeding topics, empowering mothers with the knowledge they need to succeed. Join @motifmedical on Instagram, TikTok, and their Newsletter to be a part of the fun.

Join Motif Medical in celebrating National Breastfeeding Month and show support for breastfeeding mothers everywhere. For more information about Motif Medical and their National Breastfeeding Month initiatives, please visit https://motifmedical.com/

Share article on social media or email: